. Author manuscript; available in PMC: 2011 Dec 1.

Published in final edited form as: Bone Marrow Transplant. 2011 Apr 4;46(6):884–891. doi: 10.1038/bmt.2011.77

Table 6.

Outcome Summary

	VH/Dysplasia	Invasive Carcinoma
No. of Patients	8	18
Recurrence of Invasive Carcinoma	N/A	8 (44)
New site	N/A	5 (28)
Same site	N/A	3 (12)
5 year FFR ± SE (%)^†	N/A	46 ± 15
5 year OS ± SE (%)^††	75 ± 22	70 ± 14
Time to Recurrence in months, median (range)	N/A	17 (8, 93)

^†

SE: Standard error; FFR = Freedom from recurrence. FFR was calculated from the date of diagnosis of invasive carcinoma to the date of recurrence.

^††

OS = Overall survival; OS was calculated from the date of diagnosis of secondary oral changes to the date of death.